Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol vs propofol for general anesthesia in ureteroscopic lithotripsy
ChiCTR2500115044Phase 4Not yet recruiting
- Sponsor
- Jiaxing Second Hospital
- Start
- Dec 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fospropofol disodium in nephrolithiasis (2 arms), sponsored by Jiaxing Second Hospital. Primary endpoints: Sedation success rate and Onset time of sedation effect. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on ChiCTR2500115044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115044.